CELPHI
Live / Registered — Registered (as of 14 Jan 2025)
What this means for you
Registered since 14 Jan 2025. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 14 Jan 2031: the §71 affidavit of use).
Record
- Serial number
- 79390965
- Registration number
- 7646778
- Mark type
- Word mark
- Filed
- 12 Jan 2024
- Published for opposition
- 17 Sept 2024
- Registered
- 14 Jan 2025
- Next maintenance filing
- §71 affidavit of use, due by 14 Jan 2031 (grace period to 14 Jul 2031)
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of central nervous system diseases and disorders; pharmaceutical preparations for the treatment of attention deficit hyperactivity disorder, binge eating disorder and major depressive disorder; pharmaceutical preparations, namely, smoking cessation preparations
Owner
- Otsuka Pharmaceutical Co., Ltd., Chiyoda-ku Tokyo 101-8535, JP
- Otsuka Pharmaceutical Co., Ltd., Chiyoda-ku Tokyo 101-8535, JP
- Otsuka Pharmaceutical Co., Ltd., Chiyoda-ku Tokyo 101-8535, JP
Prosecution history
- 22 Aug 2025 — NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
- 06 Aug 2025 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 06 Aug 2025 — NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
- 13 Feb 2025 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 14 Jan 2025 — REGISTERED-PRINCIPAL REGISTER
- 17 Sept 2024 — PUBLISHED FOR OPPOSITION
- 28 Aug 2024 — NOTICE OF PUBLICATION
- 04 Jul 2024 — ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
- 13 Jun 2024 — ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
- 06 Jun 2024 — ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
- 23 May 2024 — ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
- 16 May 2024 — ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
- 02 May 2024 — ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
- 29 Apr 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 24 Apr 2024 — APPLICATION FILING RECEIPT MAILED